Market Newsdesk

Peer-reviewed study identifies altered extracellular vesicles in Long COVID and provides additional scientific rationale for evaluating the Hemopurifier® as a potential treatment

SAN DIEGO, June 26, 2026 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced publication of new peer-reviewed research in the International Journal of Molecular Sciences demonstrating that patients with Long COVID exhibit significantly increased levels of mannosylated extracellular vesicles (EVs) that can be captured using the same Galanthus nivalis agglutinin (GNA) affinity resin incorporated into the Company’s Hemopurifier®.

The study, conducted in collaboration with investigators from the University of California, San Francisco (UCSF), provides what we believe is new evidence supporting extracellular vesicles as a potential therapeutic target in Long COVID and helps establish a translational framework for future studies evaluating whether the Hemopurifier can remove disease-associated EVs and their molecular cargo.

“The publication of this study contributes to the scientific understanding of the biological mechanisms underlying Long COVID while strengthening the rationale for evaluating the Hemopurifier in this significant area of unmet medical need,” said Jim Frakes, Chief Executive Officer and Chief Financial Officer of Aethlon Medical. “While the Company’s current resources and primary focus remain dedicated to advancing our Australian oncology clinical trial, these findings provide additional translational evidence supporting future preclinical and clinical studies designed to determine whether removal of these circulating extracellular vesicles may benefit patients with Long COVID. More broadly, we believe these findings reinforce the potential of the Hemopurifier as a platform technology with potential applications across multiple disease areas.  We believe there exists a ‘pipeline within a single device.'”

Key Findings

Among the study’s principal findings:

• Patients with Long COVID had approximately two-fold higher levels of mannose-positive extracellular vesicles than individuals who recovered fully following COVID-19 infection.
• Small extracellular vesicles carrying disease-associated glycosylation patterns were successfully captured using GNA affinity resin, the active binding component of the Hemopurifier.
• GNA affinity resin treatment significantly reduced seven circulating microRNAs associated with immune regulation and inflammatory signaling.
• Computational pathway analysis suggested modulation of several biologically relevant signaling pathways implicated in Long COVID, including JAK-STAT, VEGF, PI3K, and Estrogen signaling.
• The findings help establish a mechanistic link between disease-associated extracellular vesicles and the Hemopurifier’s lectin-based capture technology.

The research analyzed plasma samples from participants enrolled in UCSF’s Long-term Impact of Infection with Novel Coronavirus (LIINC) study.

The full peer-reviewed article, titled “Increased Mannosylation of Extracellular Vesicles in Long COVID Plasma as a Binding Target for Galanthus nivalis Agglutinin (GNA) Affinity Resin,” appears in the International Journal of Molecular Sciences at https://www.mdpi.com/1422-0067/27/13/5723

About Aethlon and the Hemopurifier

^®


Aethlon Medical is a medical therapeutic company focused on developing the Hemopurifier, a clinical-stage immunotherapeutic device that is designed to combat cancer and life-threatening viral infections, and for use in organ transplantation. In human studies, the Hemopurifier has demonstrated the removal of life-threatening viruses, and in pre-clinical studies, the Hemopurifier has demonstrated the removal of harmful EVs from biological fluids, utilizing its proprietary lectin-based technology. This action has potential applications in cancer, where EVs may promote immune suppression and metastasis, and in life-threatening infectious diseases. The Hemopurifier is a U.S. Food and Drug Administration (FDA) designated Breakthrough Device indicated for the treatment of individuals with advanced or metastatic cancer who are either unresponsive to or intolerant of standard of care therapy, and with cancer types in which EVs have been shown to participate in the development or severity of the disease. The Hemopurifier also holds an FDA Breakthrough Device designation and an open Investigational Device Exemption (IDE) application related to the treatment of life-threatening viruses that are not addressed with approved therapies.

Additional information can be found at www.AethlonMedical.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 that involve risks and uncertainties. Statements containing words such as “may,” “believe,” “anticipate,” “expect,” “intend,” “plan,” “project,” “will,” “projections,” “estimate,” “potentially,” or similar expressions constitute forward-looking statements. Such forward-looking statements are subject to significant risks and uncertainties, and actual results may differ materially from the results anticipated in the forward-looking statements. These forward-looking statements are based upon Aethlon’s current expectations and involve assumptions that may never materialize or may prove to be incorrect. Factors that may contribute to such differences include, without limitation, the Company’s ability to determine whether the Hemopurifier has utility in additional disease indications, including Long COVID; the Company’s ability to raise additional capital and to successfully complete development of the Hemopurifier; the Company’s ability to successfully demonstrate the utility of the Hemopurifier in cancer and infectious diseases and in the transplant setting; the ability of the Hemopurifier to continue to show removal of platelet -derived EVs at a timepoint equivalent to a 4-hour HP treatment;the manuscript described in this release being under review and may be rejected for publication, require substantial revision, or be interpreted differently by the scientific community; the Company’s ability to achieve and realize the anticipated benefits from potential milestones; the Company’s ability to submit applications to and obtain approval from the additional Ethics Committees in Australia, including on the timing expected by the Company; the Company’s ability to continue its oncology clinical trial in Australia, including on the timing expected by the Company; the Company’s ability to manage and successfully complete its clinical trials, if initiated; the Company’s ability to successfully manufacture the Hemopurifier in sufficient quantities for its clinical trials, and other potential risks. The foregoing list of risks and uncertainties is illustrative, but is not exhaustive. Additional factors that could cause results to differ materially from those anticipated in forward-looking statements can be found under the caption “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended March 31, 2026, and in the Company’s other filings with the Securities and Exchange Commission, including its quarterly Reports on Form 10-Q. All forward-looking statements contained in this press release speak only as of the date on which they were made. Except as may be required by law, the Company does not intend, nor does it undertake any duty, to update this information to reflect future events or circumstances. The preclinical findings described herein are preliminary in nature and may not be replicated in subsequent studies or clinical trials.

Company Contact:

Jim Frakes
Chief Executive Officer and Chief Financial Officer
Aethlon Medical, Inc.
[email protected]

Investor Contact:

Susan Noonan
S.A. Noonan Communications, LLC
[email protected]

 

View original content:https://www.prnewswire.com/news-releases/aethlon-medical-announces-publication-demonstrating-novel-long-covid-biomarker-and-potential-therapeutic-target-for-the-hemopurifier-302811447.html

SOURCE Aethlon Medical, Inc.

FN Media Group Presents Oilprice.com Market Commentary

NEW YORK, June 26, 2026 /PRNewswire/ — Artificial intelligence is creating a new class of infrastructure giants virtually overnight, and one innovative Bitcoin miner that made an early leap into the global power business feeding the voracious appetite of AI data centers is now being rewarded for years spent securing massive amounts of low-cost electrical power around the world.  Companies mentioned in today’s commentary includes:  Bitzero Holdings Inc.  (AIBZ), SpaceX (Nasdaq: SPCX), Oracle Corporation (NYSE: ORCL), Arm Holdings plc (NASDAQ: ARM), Micron Technology, Inc. (NASDAQ: MU), Advanced Micro Devices, Inc. (NASDAQ: AMD).

Years before artificial intelligence triggered a global race for power capacity, Bitzero Holdings (AIBZ) was using cash flow from Bitcoin mining operations to secure large amounts of low-cost electrical power across Norway, Finland, and the United States.

The company continues mining Bitcoin because the business generates strong cash flow at some of the lowest power costs in the industry. But Bitzero’s sights are now set on a much larger prize: the AI data-center buildout that McKinsey estimates could require nearly $7 trillion in global infrastructure spending by 2030, including roughly $5.2 trillion tied directly to AI workloads alone.

That prize started becoming reality on May 5, when Bitzero signed a binding letter of intent with OneQode Networks covering the full 110 MW capacity of its Namsskogan, Norway data center site under a 15-year lease tied to GPU-based AI workloads. The agreement carries an implied value of roughly $2.6 billion over the lease term, and marks Bitzero’s formal entry into the large-scale AI data-center infrastructure market.

That’s exactly why Shark Tank’s Kevin O’Leary was one of Bitzero’s earliest, and biggest backers.

O’Leary has taken on a strategic investor role in the company since its formation because he sees Bitzero as a fundamentally different kind of crypto enterprise—one rooted in energy infrastructure, not just speculation, and the data-center boom.

“If I want exposure to crypto, I only need three positions now … I own Bitzero because they mine Bitcoin and they’re actually a power company.”

The Nordic Advantage in the AI Energy Race

If cheap power built Bitcoin‘s first fortune in China, clean power is building the next one in the North Atlantic. 

Norway and Finland, home to immense hydroelectric and nuclear baseloads, have quietly become the new gravity centers for digital infrastructure.

This is the place to be for the AI infrastructure boom. Power prices across parts of the Nordic region are significantly below many major European markets. And, crucially, hydroelectric- and nuclear-heavy grids provide the kind of stable long-duration electricity AI workloads demand. Cold climates also drastically reduce cooling costs for data centers.

That’s the geography of Bitzero’s expansion strategy.

In Norway, the company’s flagship Namsskogan operation already supports active Bitcoin mining and is now becoming the foundation for its AI infrastructure business following the OneQode agreement earlier this month. Bitzero also controls additional Norwegian expansion capacity tied to a broader development pipeline that management says could eventually scale well beyond 300 MW as grid upgrades continue.

In Finland, Bitzero has secured a massive one-gigawatt development campus in Kokemäki tied directly into low-cost Nordic power infrastructure. The site gives the company room to scale both Bitcoin mining and AI compute operations over time as demand for energized capacity continues accelerating across Europe.

In the United States, Bitzero’s (AIBZ) North Dakota footprint gives the company exposure to a completely different energy and regulatory market. The site includes a 225,000-square-foot complex spread across roughly 184 acres, with additional staged power delivery planned through future expansion agreements.

What the May 5^th Lease Deal Means for Bitzero

McKinsey estimates AI infrastructure spending could approach $7 trillion globally by 2030, including more than $5 trillion tied directly to AI workloads. But that spending wave could hit a power wall as the industry discovers that building AI infrastructure isn’t just a money problem—it’s a power access problem.  The OneQode agreement officially ushers Bitzero into the lucrative world of data center power.

Now, instead of relying on Bitcoin-related mining economics, the company is moving toward a much bigger piece of the digital world. And it’s a double win for the company.

In Bitcoin mining, Bitzero uses its own electricity to generate revenue from the Bitcoin it produces. Under the AI agreement, Bitzero will generate revenue by leasing the site’s power capacity and infrastructure to OneQode the lease is to be backed by an IG counterparty as per the conditions of the binding letter. But at the same time, OneQode pays the electricity bill tied to running the AI systems inside the facility. That means Bitzero captures the recurring infrastructure revenue from the site without directly absorbing the massive ongoing power costs associated with operating large-scale AI workloads. That places Bitzero at an advantage to its peers, based on internal company research.

According to management, the OneQode agreement is structured at roughly $135 per kilowatt per month with a 3% annual escalator. At full utilization, the 110 MW Namsskogan site could generate roughly $176 million to $178 million in annual revenue. A recent shareholder analysis modeling the agreement estimated potential annual NOI of roughly $151 million based on an 85% margin profile tied to the contemplated lease structure.  

The Bigger Game At the Margins of the Data Center Boom

Across Europe and North America, AI infrastructure developers are running into transformer shortages, interconnection delays, grid congestion, and multi-year energization timelines. Many competing campuses are still years away from delivery because securing large-scale power infrastructure has become harder than securing capital. That shift is one reason public markets have started aggressively rerating companies capable of converting mining infrastructure into AI compute capacity.

Most recently, Hut 8 moved into AI infrastructure through its Fluidstack agreement, while Core Scientific secured multi-billion-dollar HPC contracts tied to CoreWeave. Investors are increasingly valuing these companies around contracted compute infrastructure and energized capacity rather than hash rate growth alone. The capital is simply following the soaring demand.

Commercial real estate giant JLL estimates global data-center capacity will nearly double by 2030, requiring almost 100 GW of new supply. Now, the single most important factor driving data-center expansion is “speed to power”, says JLL.

And with grid connection wait times in major markets already stretching beyond four years, Bitzero is ahead of its time, and the May 5^th lease deal locks in a new era for this Bitcoin innovator, backed by O’Leary and charging out of the AI power gate. 

Other companies to keep an eye on:

SpaceX (Nasdaq: SPCX)

SpaceX completed the largest IPO in history on June 12, pricing at $135 a share for a $1.77 trillion valuation and topping $2 trillion in market cap on its first trading day. The listing raised roughly $75 billion and made Elon Musk the world’s first trillionaire on paper. But the AI data center story here isn’t really about rockets. It’s about what SpaceX became after merging with xAI in February: a company that now describes itself in its own IPO filing as the operator of “the largest AI training data center clusters on Earth.”

Those clusters are Colossus 1 and Colossus 2, the xAI supercomputers built near Memphis, Tennessee, originally to train Grok. In May, SpaceX struck a deal with Anthropic that hands over essentially the entire Colossus 1 facility — more than 300 megawatts of capacity across roughly 220,000 NVIDIA GPUs, including H100, H200, and GB200 accelerators. Anthropic will pay xAI $1.25 billion a month through May 2029, a contract that could bring in more than $40 billion over its life.

Oracle Corporation (NYSE: ORCL)

Oracle spent most of the last decade being written off as legacy enterprise software. The AI infrastructure buildout has turned that narrative upside down. Q4 FY2026 revenue hit $19.2 billion, up 21% year over year, with Cloud Infrastructure (IaaS) revenue up 93%. The figure that stops people in their tracks is the remaining performance obligation: $638 billion, up $85 billion in a single quarter.

Oracle Cloud Infrastructure was always NVIDIA’s awkward middle child compared to AWS, Azure, and GCP. That’s changed. The company has been quietly signing multi-billion-dollar AI contracts, including commitments from Meta and NVIDIA itself, and built what it describes as some of the world’s fastest-growing cloud data center capacity.

Arm Holdings plc (NASDAQ: ARM)

Arm doesn’t make chips. It designs the instruction set architectures that most of the world’s chips are built on — and then collects royalties every time one of those chips ships. Every AWS Graviton processor, every Apple M-series chip, every NVIDIA Vera CPU runs on Arm architecture. Q4 FY2026 revenue hit $1.49 billion, up 20% year over year, with data center royalties more than doubling year over year for the second consecutive quarter.

The data center story for Arm is that its architecture is now winning the hyperscaler CPU market at scale. Arm-based CPUs hold approximately 50% market share among the top hyperscalers — AWS Graviton and Trainium, Google Axion and TPUs, Microsoft Cobalt, NVIDIA’s Vera CPU — all run on Arm.

Micron Technology, Inc. (NASDAQ: MU)

Every AI accelerator ships with high-bandwidth memory stacked on top of it, and Micron makes a significant share of that memory. The company reported record Q2 FY2026 revenue of $23.86 billion, up sharply year over year, with CEO Sanjay Mehrotra confirming “records across revenue, gross margin, EPS, and free cash flow.” Q3 FY2026 guidance called for revenue of $33.5 billion at roughly 81% gross margins.

The transformation of memory from commodity to strategic infrastructure is the central thesis. HBM requires specialized manufacturing processes, advanced packaging, and extremely tight integration with the accelerator it ships alongside. SK Hynix is the current leader with roughly 43% market share,

Advanced Micro Devices, Inc. (NASDAQ: AMD)

AMD reported Q1 2026 data center revenue of $5.8 billion, up 57% year over year — an all-time record — with total Q1 revenue of $10.25 billion, up 38%, beating Wall Street consensus by roughly $350 million. Free cash flow more than tripled to $2.57 billion. CEO Lisa Su called the quarter “a clear inflection in our growth trajectory,” and guided Q2 revenue to $11.2 billion, with server CPU revenue alone expected to grow more than 70% year over year.

AMD’s data center story runs on two rails that NVIDIA’s does not. First, EPYC server CPUs, which now hold significant market share in hyperscaler deployments across AWS, Google Cloud, and Microsoft Azure, deliver four consecutive quarters of record server CPU revenue. Second, Instinct GPUs are gaining traction as an alternative to NVIDIA in AI training and inference — and the demand signal is large.

By. Michael Kern

IMPORTANT NOTICE AND DISCLAIMER

Neither the author nor the publisher, Oilprice.com, was paid to publish this communication concerning Bitzero Holdings, Inc. (AIBZ). The owner of Oilprice.com owns shares and/or stock options of the featured company and therefore has an incentive to see the featured company’s stock perform well. The owner of Oilprice.com may buy or sell shares of the featured company at any time including at or near the time you receive this communication. This share ownership should be viewed as a major conflict with our ability to be unbiased. This is why we stress that you conduct extensive due diligence as well as seek the advice of your financial advisor or a registered broker-dealer before investing in any securities.

This communication is not, and should not be construed to be, an offer to sell or a solicitation of an offer to buy any security. Neither this communication nor the Publisher purport to provide a complete analysis of any company or its financial position. The Publisher is not, and does not purport to be, a broker-dealer or registered investment adviser. This communication is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a professional investment advisor and only after reviewing the financial statements and other pertinent corporate information about the company. Further, readers are advised to read and carefully consider the Risk Factors identified and discussed in the advertised company’s SEC, SEDAR and/or other government filings. Investing in securities is speculative and carries a high degree of risk. Past performance does not guarantee future results. This communication is based on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the Publisher cannot guarantee the accuracy or completeness of the information.

INDEMNIFICATION/RELEASE OF LIABILITY. By reading this communication, you acknowledge that you have read and understand this disclaimer, and further that to the greatest extent permitted under law, you release the Publisher, its affiliates, assigns and successors from any and all liability, damages, and injury from this communication. You further warrant that you are solely responsible for any financial outcome that may come from your investment decisions.

TERMS OF USE. By reading this communication you agree that you have reviewed and fully agree to the Terms of Use found here http://oilprice.com/terms-and-conditions If you do not agree to the Terms of Use http://oilprice.com/terms-and-conditions, please contact Oilprice.com to discontinue receiving future communications.

INTELLECTUAL PROPERTY. Oilprice.com is the Publisher’s trademark. All other trademarks used in this communication are the property of their respective trademark holders.  The Publisher is not affiliated, connected, or associated with, and is not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made by the Publisher to any rights in any third-party trademarks.

DISCLAIMER:  OilPrice.com is Source of all content listed above.  FN Media Group, LLC (FNM), is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with OilPrice.com or any company mentioned herein.  The commentary, views and opinions expressed in this release by OilPrice.com are solely those of OilPrice.com and are not shared by and do not reflect in any manner the views or opinions of FNM.  FNM is not liable for any investment decisions by its readers or subscribers.  FNM and its affiliated companies are a news dissemination and financial marketing solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security.  FNM was compensated twenty one hundred dollars by Bitzero Holdings Inc. to distribute news commentary releases.  It is important to note that Oilprice.com, source of this release, was not paid to publish this communication concerning Bitzero Holdings, Inc. in any manner whatsoever and has no affiliation with Bitzero Holdings, Inc. #tickertagpressreleases #pressrelease #stockalerts

FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected,” “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements.

Contact Information:

Media Contact e-mail:  [email protected]
U.S. Phone: +1(561)486-1799
OilPrice.com
+44 203 239 4080
[email protected]

View original content:https://www.prnewswire.com/news-releases/the-ai-booms-biggest-bottleneck-is-creating-billion-dollar-opportunities-302811140.html

SOURCE OilPrice.com

TOKYO, June 26, 2026 /PRNewswire/ — TOYO Co., Ltd. (Nasdaq: TOYO) (OTC: TOYWF), (“TOYO” or the “Company”), a solar manufacturing company, today announced the closing on June 25, 2026 of its previously announced registered direct offering of an aggregate of 4,545,456 ordinary shares and warrants to purchase up to 4,545,456 ordinary shares, at a combined purchase price of $11.00 per share and associated warrant.

The warrants issued in the offering have an exercise price of $13.20 per share, are exercisable immediately upon issuance, and will expire five years from the date of issuance.

Roth Capital Partners and H.C. Wainwright & Co. acted as the exclusive co-placement agents for the offering. The Company was represented by Robinson & Cole LLP as its legal counsel, and Roth Capital Partners and H.C. Wainwright & Co. were represented by Pryor Cashman LLP as their legal counsel.

The aggregate gross proceeds to the Company from the offering were approximately $50 million, before deducting the placement agent fees and other offering expenses payable by the Company. The Company intends to use the net proceeds from the offering to build its previously announced 1.5 GW heterojunction (HJT) solar cell manufacturing facility in the Houston metropolitan area, Texas, as well as for general corporate purposes.

The securities described above were offered pursuant to a “shelf” registration statement (File No. 333-290952) that was filed with the Securities and Exchange Commission (“SEC”) on October 20, 2025 and became effective on November 9, 2025. The offering was made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. The prospectus supplement and the accompanying prospectus relating to the offering have been filed with the SEC and are available at the SEC’s website at www.sec.gov. Electronic copies of the prospectus supplement and the accompanying prospectus relating to the offering may also be obtained by contacting Roth Capital Partners, LLC, 888 San Clemente, Suite 400, Newport Beach, CA 92660, (800) 678-9147 or by email at [email protected] or by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3^rd Floor, New York, NY 10022, by telephone at (212) 856-5711 or e-mail at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or jurisdiction.

About TOYO Co., Ltd.

TOYO is a solar manufacturing company that is committed to becoming a vertically integrated solar manufacturer in the global market, integrating the upstream production of wafers and silicon, midstream production of solar cells, downstream production of photovoltaic modules, and potentially other stages of the solar power supply chain. TOYO is well-positioned to produce high-quality solar cells and modules at a competitive scale and cost.

Forward Looking Statements 

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “estimate,” “plan,” “project,” “forecast,” “intend,” “will,” “expect,” “anticipate,” “believe,” “seek,” “target” or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements related to the intended use of net proceeds from the the registered direct offering. These statements are based on various assumptions, whether or not identified in this press release, and on the current expectations of TOYO’s management and are not predictions of actual performance.

These statements involve risks, uncertainties, and other factors that may cause actual results, activity levels, performance, or achievements to materially differ from those expressed or implied by these forward-looking statements. These include market and other conditions, the outcome of any potential litigation, government or regulatory proceedings, the sales performance of TOYO, and other risks and uncertainties, including but not limited to those included under the heading “Risk Factors” in the filings of TOYO with the SEC. Although TOYO believes that it has a reasonable basis for each forward-looking statement contained in this press release, TOYO cautions you that these statements are based on a combination of facts and factors currently known and projections of the future, which are inherently uncertain. In addition, there are risks and uncertainties described in the documents filed by TOYO from time to time with the SEC. These filings may identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. Except as may be required by law, TOYO does not undertake any duty to update these forward-looking statements.

Contact Information

For TOYO Co., Ltd.


[email protected]
 

Crocker Coulson
Email: [email protected] 
Tel: (646) 652-7185

View original content:https://www.prnewswire.com/news-releases/toyo-co-ltd-announces-closing-of-50-million-registered-direct-offering-302811736.html

SOURCE TOYO Co., Ltd.

NORTH CHICAGO, Ill., June 26, 2026 /PRNewswire/ — AbbVie (NYSE: ABBV) will announce its second-quarter 2026 financial results on Friday, July 31, 2026, before the market opens. AbbVie will host a live webcast of the earnings conference call at 8 a.m. Central time. It will be accessible through AbbVie’s Investor Relations website at investors.abbvie.com. An archived edition of the session will be available later that day.

About AbbVie

AbbVie’s mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people’s lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn,Facebook, Instagram, X and YouTube.

 

View original content:https://www.prnewswire.com/news-releases/abbvie-to-host-second-quarter-2026-earnings-conference-call-302810896.html

SOURCE AbbVie

Award continues program expansion capacity to meet rising domestic and international demand

TUCSON, Ariz., June 26, 2026 /PRNewswire/ — Raytheon, an RTX (NYSE: RTX) business, was awarded a $1.1 billion contract from the U.S. Navy to produce AIM-9X Block II missiles to bolster U.S. military inventory and meet increased demand from allied nations.

Under the contract, Raytheon will produce AIM-9X missiles along with associated hardware and software for U.S. and Foreign Military Sales customers.

“Our teams have streamlined production, shortened lead times and ramped up deliveries of AIM-9X missiles to keep pace with growing demand,” said Barbara Borgonovi, president of Naval Power at Raytheon. “This contract, along with our close partnership with the U.S. Navy, allows us to sustain that momentum and ensure U.S. and allied forces have this advanced, combat-proven capability they depend on in high threat environments.”

AIM-9X is the most advanced infrared tracking, short-range air-to-air and surface-to-air missile, and it is combat-proven in multiple theaters around the world. The system is configured for easy installation on a wide range of modern aircraft and provides layered defense options with ground launched capabilities, including the National Advanced Surface to Air Missile System (NASAMS).

Trusted by the U.S. and more than 35 allied and partner nations, AIM-9X is a critical asset for ensuring strategic deterrence and operational advantage worldwide. To meet growing demand, Raytheon is increasing its production capacity to 2,500 missiles per year.

A majority of the work under this contract will take place in Tucson, Arizona. Raytheon is significantly expanding its engineering workforce in Tucson to support critical military programs across domains. Engineers with active security clearances and relevant technical experience ready to make a difference helping connect and protect our world can learn more by visiting our website.

About Raytheon
Raytheon, an RTX business, is a leading provider of defense solutions to help the U.S. government, our allies and partners defend their national sovereignty and ensure their security. For more than 100 years, Raytheon has developed new technologies and enhanced existing capabilities in integrated air and missile defense, smart weapons, missiles, advanced sensors and radars, interceptors, space-based systems, hypersonics and missile defense across land, air, sea and space.

About RTX
With more than 180,000 global employees, we push the limits of technology and science to redefine how we connect and protect our world. With industry-leading capabilities, we advance aviation, engineer integrated defense systems for operational success, and develop next-generation technology solutions and manufacturing to help global customers address their most critical challenges. The company, with 2025 sales of more than $88 billion, is headquartered in Arlington, Virginia.

For questions or to schedule an interview, please contact

[email protected]
.

View original content:https://www.prnewswire.com/news-releases/rtxs-raytheon-awarded-1-1-billion-us-navy-contract-to-produce-aim-9x-block-ii-missiles-302811401.html

SOURCE RTX

Three semi stocks, a networking stalwart and a quantum computing name set to receive the Tradr treatment

NEW YORK, June 26, 2026 /PRNewswire/ — Tradr ETFs, a provider of ETFs designed for sophisticated investors and professional traders, announced that it expects to launch five single stock leveraged ETFs on Wednesday, July 1. The Cboe-listed funds seek to deliver two times (200%) the daily performance of a specific underlying stock.

Expected Tradr launches:

• Tradr 2X Long CIEN Daily ETF (Cboe: CIEX) – tracks Ciena Corporation (NYSE: CIEN)
• Tradr 2X Long QNT Daily ETF (Cboe: QNTU) – tracks Quantinuum Inc. (Nasdaq: QNT)
• Tradr 2X Long RMBS Daily ETF (Cboe: RMBX) – tracks Rambus Inc. (Nasdaq: RMBS)
• Tradr 2X Long TSEM Daily ETF (Cboe: TSEU) – tracks Tower Semiconductor Ltd. (Nasdaq: TSEM)
• Tradr 2X Long TTMI Daily ETF (Cboe: TTMX) – tracks TTM Technologies, Inc. (Nasdaq: TTMI)

For detailed information on Tradr ETFs and the significant risks involved with leveraged ETFs, please visit www.tradretfs.com.

About Tradr ETFs
Tradr ETFs are designed for sophisticated investors and professional traders who are looking to express high conviction investment views. The strategies include leveraged and inverse ETFs that seek short or long exposure to actively traded stocks and ETFs.

IMPORTANT RISK INFORMATION

Tradr ETFs are for sophisticated investors and professional traders with high conviction views and are very different from most other ETFs. The Funds are intended to be used as short-term trading vehicles and pursue leveraged investment objectives, which means they are riskier than alternatives that do not use leverage because the Funds magnify the performance of their underlying security. The volatility of the underlying security may affect a Fund’s return as much as, or more than, the return of the underlying security.

Investors in the fund should: (a) understand the risks associated with the use of leverage; (b) understand the consequences of seeking inverse and leveraged investment results; (c) for short ETFs, understand the risk of shorting; (d) intend to actively monitor and manage their investment. Fund performance will likely be significantly different than the benchmark over periods longer than the specified reset period and the performance may trend in the opposite direction than its benchmark over periods other than that period.

Leverage increases the risk of a total loss of an investor’s investment, may increase the volatility of the Funds, and may magnify any differences between the performance of the Funds and their reference security. The Funds seek leveraged investment results for a specific period (daily, monthly or quarterly). The exact exposure of an investment in the Fund intra-period will depend upon the movement of the reference security from the end of the prior period until the time of investment by the investor.

The Fund will not attempt to position its portfolio to ensure it does not gain or lose more than a maximum percentage of its net asset value on a given trading day. As a consequence, investors in a Fund that seeks two times daily performance would lose all of their money if the Fund’s underlying security moves more than 50% in a direction adverse to the Fund on a given trading day.

ETFs involve risk including possible loss of the full principal value. There is no assurance that the Fund will achieve its investment objective. Principal risks and other important risks may be found in the prospectus. Past performance does not guarantee future results.

ETF shares are bought and sold at market price (not NAV) and are not individually redeemed from the ETF. There can be no guarantee that an active trading market for ETF shares will develop or be maintained, or that their listing will continue or remain unchanged. Buying or selling ETF shares on an exchange may require the payment of brokerage commissions and frequent trading may incur brokerage costs that detract significantly from investment returns.

Investors should carefully consider the investment objectives, risks, charges and expenses of the Funds. This and other important information about the Fund is contained in the Prospectus, which can be obtained by visiting www.tradretfs.com. The Prospectus should be read carefully before investing.

Distributed by ALPS Distributors, Inc, which is not affiliated with AXS Investments or its Tradr ETFs. AXI000977

View original content to download multimedia:https://www.prnewswire.com/news-releases/tradr-to-launch-leveraged-etfs-on-cien-qnt-rmbs-tsem–ttmi-302811176.html

SOURCE Tradr ETFs

• 
  Transformative acquisitions of IndiCue and Giant Worldwide complete Cineverse’s evolution into an AI-driven, fully integrated entertainment technology company and studio, contributing $11.6 million of revenue in their first partial quarter and unlocking durable, recurring revenue streams
  
• Fourth Quarter Revenue of $26.0 Million, a $10.4 Million or 67% Increase Over the Prior Year Quarter
• Fourth Quarter Net Income Attributable to Common Stockholders of $1.1 Million, a 51% Increase Over the Prior Year Quarter
• Targeted Annualized Cost Reductions and Synergies Increased to Approximately $10 Million; $2 Million Completed by March 2026.
• Cineverse Reaffirms Fiscal Year 2027 (Began on April 1, 2026) Guidance of $115 to $120 Million of Revenue — Approximately 75% to 83% Growth — and $10 to $20 Million of Adjusted EBITDA, with Technology Platforms Expected to Represent More Than 50% of Total Revenue

LOS ANGELES, June 26, 2026 /PRNewswire/ — Cineverse Corp. (“Cineverse” or the “Company”) (NASDAQ: CNVS), a global streaming technology and entertainment company, today announced its financial results for its fiscal fourth quarter (“Q4 FY 2026”) and full year ended March 31, 2026 (“FY 2026”):

Fourth Quarter 2026 Highlights

(All comparisons are to the prior year fiscal quarter ended March 31, 2025, or “Q4 FY 2025”)

• Total revenue increased 67% to $26.0 million from $15.6 million in Q4 FY 2025, driven by $11.6 million in advertising technology and media services revenue resulting from the acquisitions of Giant Worldwide (“Giant”) and IndiCue, Inc. (“IndiCue”) (together, the “Acquisitions”) in their first partial quarter, alongside continued solid performance across the Company’s base streaming, technology, and content businesses, highlighted by the more than 50% growth in both streaming viewers and minutes streamed compared to Q4 FY 2025. The Acquisitions closed on January 7, 2026 and February 12, 2026, respectively, leading to the recognition of the partial results during the quarter. Our next reported quarter will recognize full quarterly results for both the acquired entities.
• Net income attributable to common stockholders of $1.1 million, or $0.05 per share, compared to $0.8 million, or $0.04 per share, in Q4 FY 2025, including a $4.3 million non-cash bargain purchase gain from the Giant acquisition and a $2.9 million income tax benefit primarily related to the IndiCue acquisition. Total net income was $1.3 million, a 49% increase versus the prior year period.
• Adjusted EBITDA of $0.1 million
  
  ⁽¹⁾
  , compared to $4.0 million in Q4 FY 2025, reflecting deliberate investment in M&A execution, acquisition integration and marketing during the quarter — costs the Company expects to substantially reduce as acquisition integration is completed;
• Direct operating margin of 40% compared to 55% in Q4 FY 2025, reflecting the integration of the Acquisitions and partially indicative of the go-forward margin profile of the combined, more diversified business;
• Closed two strategic acquisitions in a single quarter: connected TV monetization platform IndiCue and media services provider Giant Worldwide, now a Matchpoint™ company, vertically expanding Cineverse into advertising technology and media services;
• Completed approximately $2.0 million in annualized SG&A cost reductions by March 2026, the first step in the Company’s previously announced $7.5 million cost reduction program, with the vast majority of the remaining $5.5 million expected to be realized by the end of the second quarter of fiscal 2027.

Full-Year 2026 Highlights

(All comparisons are to the prior fiscal year ended March 31, 2025, or “FY 2025”)

• Full-year revenue of $65.7 million compared to $78.2 million in FY 2025, a 16% decrease primarily reflecting the exceptional prior-year theatrical and ancillary contribution of Terrifier 3, the most successful unrated film release of all time, partially offset by $11.6 million of revenue contribution from the Acquisitions;
• Direct operating costs decreased $8.1 million, primarily due to lower royalty expenses associated with the decline in Terrifier 3 revenues;
• SG&A expenses increased $15.6 million, or 56%, primarily due to higher marketing costs associated with an expanded theatrical release slate, as well as M&A, acquisition integration and compensation costs related to the Acquisitions;
• Net loss attributable to common stockholders of $(9.2) million, or $(0.49) per diluted share, compared to net income of $3.2 million, or $0.16 per diluted share, in FY 2025;
• Adjusted EBITDA of $(3.4) million compared to $13.9 million in FY 2025, reflecting the difficult Terrifier 3 comparison and acquisition-related investment that positions the Company for substantial growth in fiscal 2027.

Fiscal 2026 was a transformative year for Cineverse. In a single quarter, the Company completed two strategic acquisitions — Giant Worldwide in January 2026 and IndiCue in February 2026 — that together vertically expand Cineverse into AI-driven advertising technology and media services, further diversify the Company’s revenue base beyond entertainment content and streaming performance, and add significant new durable, recurring revenue streams. The Acquisitions contributed $11.6 million of revenue in their first partial quarter and are the foundation of the Company’s reaffirmed fiscal 2027 guidance of $115 to $120 million of revenue and $10 to $20 million of Adjusted EBITDA — representing approximately 75% to 83% revenue growth over fiscal 2026.⁽³⁾

Net income for the quarter benefited from a $4.3 million one-time, non-cash bargain purchase gain on the Giant acquisition, as detailed in the Adjusted EBITDA reconciliation below, as well as income tax benefits primarily driven by the IndiCue acquisition. While the bargain purchase gain is non-cash and non-recurring, it is strongly indicative of the quality of the deal price and the value creation opportunity the Company is beginning to realize from Giant.

Fiscal 2027 Outlook and Cost Reduction Trajectory

The Company reaffirms the fiscal 2027 guidance first issued in February 2026 in connection with the Acquisitions: revenue of $115 to $120 million and Adjusted EBITDA of $10 to $20 million. Key components of this outlook, each consistent with the Company’s prior public disclosures, include:

• Acquisition contribution: the Acquisitions are expected to contribute more than $50 million of revenue in fiscal 2027. A significant portion of these revenues are recurring in nature and derived from ongoing service relationships with major Hollywood studio and streaming platform clients;
• Majority technology revenue: technology platforms are expected to represent more than 50% of total fiscal 2027 revenue, completing Cineverse’s transition to a business led by scalable, recurring infrastructure economics;
• $7.5 million SG&A cost reduction program: guidance incorporates the Company’s previously announced $7.5 million cost reduction program. Approximately $2.0 million in reductions were already completed by March 2026, and the Company remains on track to realize the vast majority of the remaining $5.5 million by the end of the second quarter of fiscal 2027 (September 30, 2026), driven in large part by finalizing integration of the Acquisitions, further leveraging Cineverse Services India, and further implementation of AI technology;
• Giant Worldwide integration synergies: within the first year of ownership, the Company anticipates approximately $2.5 million of additional annualized cost synergies from the integration of Giant’s services into the Matchpoint™ platform — bringing total identified annualized cost reductions and synergies to approximately $10 million;
• Revenue synergy upside: revenue synergies will be generated by cross-selling across Matchpoint™, IndiCue and Giant’s combined client base — including shortened sales cycles and expanded service offerings to existing studio and streaming platform relationships — representing potential upside not fully reflected in current guidance.

Management Commentary

Chris McGurk, Cineverse Chairman and CEO, stated: “We feel that Fiscal 2026 was one of the most consequential years in Cineverse’s history. Following the unprecedented success of Terrifier 3, the biggest unrated film release in history, we moved quickly and decisively to convert that momentum into a structurally stronger and even higher growth company — completing the acquisitions of Giant Worldwide and IndiCue in a single quarter. These deals fundamentally change what Cineverse is as a company. We are now a technology-first, AI-driven, fully integrated entertainment company with three powerful and mutually reinforcing engines — a proven, low-risk, high potential return wide release film slate strategy; a scaled streaming and podcast portfolio; and now a vertically integrated advertising technology and media services business built around our Matchpoint™ platform. The positive financial impact of this has been immediate, with the Acquisitions contributing $11.6 million of revenue in their first partial quarter and driving 67% total revenue growth. We fully expect the financial contribution from the Acquisitions to be even more significant in our next reported quarter based on strong preliminary results recorded to date.”

“The strategic logic of these two transactions cannot be overstated. IndiCue brings a connected TV monetization platform serving more than 40 live clients, with an additional 75 publishers onboarding to the table. Giant Worldwide, now a Matchpoint™ company, brings deep and long-standing studio relationships directly into our automated media services ecosystem. Combined, all of this creates a powerful flywheel: Matchpoint’s automated content supply chain feeds IndiCue’s monetization engine, and IndiCue’s advertiser demand increases the value of every channel, film and TV title and partner we serve. That flywheel — not any single film or streaming channel or distribution agreement — is the growth and performance engine behind our fiscal 2027 guidance of $115 to $120 million in revenue and $10 to $20 million of Adjusted EBITDA, which we are reaffirming today.”

“At the same time, our franchise film strategy continues to perform exactly as designed — high upside with minimal financial risk. Our upcoming slate includes the 20th anniversary theatrical re-release of Guillermo del Toro’s Oscar-winning masterpiece Pan’s Labyrinth, presented for the first time in 4K and 3D formats, in October 2026, the nationwide theatrical relaunch of the beloved Air Bud family franchise in January 2027, and the latest installment of the Wolf Creek horror franchise in March 2027. Each of these films follows the Terrifier 2 and 3 blueprint of acquiring well known IP properties with avid built-in fan bases that have high upside potential and minimal financial risk to the Company and will generate long term recurring revenues by driving viewers and subscribers to our streaming channels, and becoming valuable long term additions to our library. With the integration of our Acquisitions on track, approximately $10 million of identified annualized cost reductions and synergies — including the $2 million in SG&A reductions we completed in January — and a clear line of sight to our guidance, we believe fiscal 2027 will demonstrate the full scale, trajectory, upside potential and earnings power of the new Cineverse.”

Erick Opeka, Cineverse President and Chief Strategy Officer, stated: “This quarter marks the completion of Cineverse’s evolution into a platform-first entertainment company. The Giant and IndiCue acquisitions connect distribution, data, and monetization into a single, unified solution, positioning Matchpoint™ as the only full-stack streaming distribution and monetization platform for studios and global digital platforms — and we are already compounding those advantages. Subsequent to quarter-end, we unveiled Matchpoint Hex™, an AI-powered ‘Human Experience’ metadata layer built on the acquired IndiCue technology, launched Gorilla Comedy+ powered by Matchpoint, and expanded distribution with new Roku SVOD channels. Our SCREAMBOX horror service grew subscribers 18% year-over-year, demonstrating the durability of our fandom-channel strategy.”

“At the same time, we are maintaining the cost discipline we committed to last quarter. We completed approximately $2 million in SG&A cost reductions by March 2026 and remain on track to realize the vast majority of the remaining $5.5 million of our $7.5 million cost reduction program by the end of the second quarter of fiscal 2027, while also capturing approximately $2.5 million in annualized synergies from integrating Giant into Matchpoint™. Looking ahead, we are focused on becoming a unique, truly AI-native entertainment studio, with AI playing a critical role not just in distribution and monetization and cost control, but in development and production as well.“

Fourth Quarter Results

Revenues in Q4 FY 2026 increased $10.4 million, or 67%, to $26.0 million from $15.6 million in Q4 FY 2025. The growth was primarily driven by $11.6 million in advertising technology and media services revenue, contributed by the Acquisitions in their first partial quarter with the Company. The Acquisitions were finalized on January 7, 2026 and February 12, 2026, respectively, leading to the recognition of partial results during the quarter. Our next reported quarter will recognize full results for the acquired entities.

Direct operating margin for the quarter was 40%, compared to 55% in the prior year quarter, in part attributable to the effect of the integration of the Acquisitions and partially reflective of the go-forward margin profile of the combined, more diversified business.

SG&A expenses increased $6.9 million, or 127%, primarily due to a $2.2 million increase in marketing spend supporting the Company’s expanded theatrical slate, $1.0 million in M&A and acquisition integration costs, and $0.6 million of stock-based compensation. The Company has already completed approximately $2.0 million of the $7.5 million in targeted annualized SG&A cost reductions announced last quarter, and expects to realize the vast majority of the remaining $5.5 million by the end of the second quarter of fiscal 2027 as it completes the integration of the Acquisitions and further leverages Cineverse Services India.

Net income attributable to common stockholders was $1.1 million, or $0.05 per diluted share, compared to $0.8 million, or $0.04 per diluted share, in Q4 FY 2025. Net income benefited from the $4.3 million bargain purchase gain on the Giant acquisition and a $2.9 million income tax benefit, primarily stemming from the IndiCue acquisition.

Adjusted EBITDA was $0.1 million compared to $4.0 million in Q4 FY 2025, primarily due to the SG&A increases related to M&A, integration and marketing costs noted above.

Full-Year Results

FY 2026 consolidated revenue was $65.7 million compared to $78.2 million in FY 2025, a 16% decrease primarily driven by the comparison to the significant prior-year theatrical and ancillary revenues generated by Terrifier 3. This decline was partially offset by the $11.6 million revenue contribution from the Acquisitions in Q4 FY 2026. Correspondingly, direct operating costs decreased $8.1 million, primarily due to lower royalty expenses.

SG&A expenses increased $15.6 million, or 56%, compared to FY 2025, primarily due to higher marketing costs associated with a greater number of theatrical releases, as well as higher M&A, acquisition integration and compensation costs related to the Acquisitions.

Net loss attributable to common stockholders was $(9.2) million, or $(0.49) per diluted share, compared to net income of $3.2 million, or $0.16 per diluted share, in FY 2025. Adjusted EBITDA was $(3.4) million compared to $13.9 million in FY 2025.

Financial Condition Overview

• Cash and cash equivalents of $3.4 million as of March 31, 2026;
• The Company maintains its $12.5 million line of credit facility (expandable to $15.0 million) with East West Bank with a term through April 8, 2028, with $9.4 million drawn as of March 31, 2026;
• The Company’s working capital deficit of $(12.2) million as of March 31, 2026 includes the IndiCue acquisition’s current deferred consideration liability of $12.2 million which can be settled in equity; excluding this equity-settleable deferred consideration, the Company ended the year with positive working capital;
• The Company’s digital content library, comprised of more than 66,000 titles, was independently valued at approximately $45 million as of March 31, 2025, well above its $5.1 million book value as of March 31, 2026.

Operational Developments During the Quarter

• Announced the acquisition of Giant Worldwide (now a Matchpoint™ company) and the integration of its services into the Matchpoint™ platform — bringing deep studio relationships into the Company’s automated media services ecosystem — along with a new leadership team for Giant;
• Ended the quarter with streaming viewers up 66% to 129.6 million, and total minutes streamed rose 58% to 4.4 billion for the quarter, along with 1.52 million SVOD subscribers, up 13%, each compared to Q4 FY 2025.  
• Announced the acquisition of connected TV monetization platform IndiCue, which serves more than 40 live clients with an additional 75 publishers onboarding;
• Announced that streaming rights to the film The Toxic Avenger have been acquired by Hulu; after this exclusivity window ends on July 31, 2026, fans will be able to watch the film on other SVOD and FAST streamers, including Cineverse’s flagship horror channel, SCREAMBOX;
• Cineverse and its Bloody Disgusting unit unveiled the new programming slate for the SCREAMBOX horror streamer, highlighting the return of Bloody Bites (season 16) and exclusive titles (including The Toxic Avenger), amid an 18% year-over-year increase in SCREAMBOX subscribers;
• Cineverse and Air Bud Entertainment announced that Air Bud Returns will be released theatrically nationwide on January 22, 2027, relaunching the classic Air Bud family franchise on the big screen;
• Expanded Cineverse’s technology offerings through a partnership between Matchpoint™ and Revry, enabling automated content management and delivery of thousands of assets across hundreds of distribution platforms;
• Announced a strategic partnership with VA Media to grow and monetize Cineverse’s lineup of YouTube channels, beginning with the Dog Whisperer with Cesar Millan channel, and expanding viewership and advertising revenue across Cineverse’s digital brands;
• Launched Matchpoint™ Creative Labs, a new in-house creative agency unit using generative AI to produce motion-first advertising, on-air promotions and branding for connected TV and FAST channels;
• Announced the start of production for the next installment of the Wolf Creek horror franchise — the first two films in the Australian slasher series grossed more than $35 million globally at theaters.

Operational Developments Subsequent to Quarter-End

• Unveiled Matchpoint Hex™, an AI-powered “Human Experience” metadata layer for film and TV; Hex integrates the acquired IndiCue technology, sits atop Cineverse’s Matchpoint platform, and uses a proprietary taxonomy on a dataset of more than 2 million titles;
• Announced that Silent Night, Deadly Night (Certified Fresh on Rotten Tomatoes) will stream exclusively on SCREAMBOX starting April 28, 2026;
• Announced the 20th anniversary wide theatrical re-release of Pan’s Labyrinth in partnership with Fathom Entertainment on October 9, following the celebration of the film’s first 4K/3D presentation at Cannes Classics (May 12, 2026) with Guillermo del Toro in attendance; the film is Oscar-winning and “Certified Fresh” (95% Rotten Tomatoes score);
• 800 Pound Gorilla, a comedy distributor, launched Gorilla Comedy+, a premium, ad-free streaming service powered by Cineverse’s Matchpoint platform; the service (launched May 5, 2026) features more than 250 comedy specials, and Gorilla’s network (3.1 million social followers) reaches over 20 million comedy fans monthly;
• Launched two new Roku SVOD channels — “So … Real”and the flagship “Cineverse” channel — via Roku’s Premium Subscriptions in the U.S., expanding Cineverse’s content distribution through Roku;
• Announced that Sean McCabe is joining as Chief Financial Officer, returning to the Company where he served as Vice President and Corporate Controller in 2023 and 2024; he rejoins Cineverse from Freestar, a major player in the ad-tech space.

Conference Call

Cineverse will host a conference call at 8:30 a.m. ET (Friday, June 26, 2026), during which management will discuss the results of the fiscal fourth quarter and year ended March 31, 2026. To participate in the conference call, please use the following dial-in numbers:

North America (Toll-Free): +1 833 439 1904
North America (Local): +1 206 407 3444
Meeting ID: 778 325 053
Access Code: 313318

The conference call can also be accessed by webcast at the Investors section of the Company’s website at https://events.q4inc.com/attendee/778325053. Those who are unable to attend the live conference call may access the recording at the above webcast link, which will be made available shortly after the conclusion of the call.

About Cineverse

Cineverse (Nasdaq: CNVS) is an entertainment technology company and studio. Fiercely innovative and independent, Cineverse develops and invests in technology and content that drives the future of the industry. Core to its business is Matchpoint® – a growing tech ecosystem powered by AI and designed to prepare, distribute, monetize, and continuously improve content across any platform. Matchpoint helps studios large and small operate at scale and improve performance and efficiency in an increasingly fragmented distribution environment. Additionally, Cineverse distributes more than 66,000 premium films, series, and podcasts across theatrical, home entertainment, and streaming; operates dozens of digital properties that super serve passionate fandoms around the world; and works with leading brands to connect them with audiences they value. From award-winning technology to the highest-grossing unrated film in U.S. history, Cineverse has created a playbook that marries tech and content to redefine the next era of entertainment. For more information, visit home.cineverse.com.

Safe Harbor Statement

Investors and readers are cautioned that certain statements contained in this document, as well as some statements in periodic press releases and some oral statements of Cineverse officials during presentations about Cineverse, along with Cineverse’s filings with the Securities and Exchange Commission, including Cineverse’s registration statements, quarterly reports on Form 10-Q and annual report on Form 10-K, are “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Act”). Forward-looking statements include statements that are predictive in nature, which depend upon or refer to future events or conditions, which include words such as “expects,” “anticipates,” “intends,” “plans,” “could,” “might,” “believes,” “seeks,” “estimates” or similar expressions. In addition, any statements concerning future financial performance (including future revenues, earnings, or growth rates), ongoing business strategies or prospects, and possible future actions, which may be provided by Cineverse’s management, are also forward-looking statements as defined by the Act. Forward-looking statements are based on current expectations and projections about future events and are subject to various risks, uncertainties, and assumptions about Cineverse, its technology, economic and market factors, and the industries in which Cineverse does business, among other things. These statements are not guarantees of future performance, and Cineverse undertakes no specific obligation or intention to update these statements after the date of this release.

For additional information, please contact:
Julie Milstead
424-281-5411
[email protected]

 

 

 

Adjusted EBITDA

We define Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, stock-based compensation expense, merger and acquisition costs, restructuring, transition and acquisitions expense, net, goodwill impairment and certain other items.

Adjusted EBITDA is not a measurement of financial performance under GAAP and may not be comparable to other similarly titled measures of other companies. We use Adjusted EBITDA as a financial metric to measure the financial performance of the business, because management believes it provides additional information with respect to the performance of its fundamental business activities. For this reason, we believe Adjusted EBITDA will also be useful to others, including our stockholders, as a valuable financial metric.

We present Adjusted EBITDA because we believe that Adjusted EBITDA is a useful supplement to net income (loss) from continuing operations as an indicator of operating performance. We also believe that Adjusted EBITDA is a financial measure that is useful both to management and investors when evaluating our performance and comparing our performance with that of our competitors. We also use Adjusted EBITDA for planning purposes, and to evaluate our financial performance because Adjusted EBITDA excludes certain incremental expenses or non-cash items, such as stock-based compensation charges, that we believe are not indicative of our ongoing operating performance.

We believe that Adjusted EBITDA is a performance measure and not a liquidity measure, and therefore a reconciliation between net income (loss) from operations and Adjusted EBITDA has been provided in the financial results. Adjusted EBITDA should not be considered as an alternative to net income (loss) from operations as an indicator of performance, or as an alternative to cash flows from operating activities as an indicator of cash flows, in each case as determined in accordance with GAAP, or as a measure of liquidity. In addition, Adjusted EBITDA does not take into account changes in certain assets and liabilities as well as interest and income taxes that can affect cash flows. We do not intend the presentation of these non-GAAP measures to be considered in isolation or as a substitute for results prepared in accordance with GAAP. These non-GAAP measures should be read only in conjunction with our consolidated financial statements prepared in accordance with GAAP.

Following is the reconciliation of our consolidated net income (loss) to Adjusted EBITDA (in thousands):

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/cineverse-reports-fourth-quarter-and-fiscal-year-2026-results-302811469.html

SOURCE Cineverse Corp.